Loading company…
Poitiers-based biotech developing Tumor Activated Therapy, which activates treatments in the presence of tumor markers.
Seekyo Therapeutics was founded in 2018 and is based in Poitiers, France, by Oury Chetboun and Sébastien Papot. Its Tumor Activated Therapy aims to target cancerous tumors and reduce side effects, and it is offered to hospitals and oncology clinics mainly in North America and Europe. The company has completed three funding rounds, the most recent raising EUR 459,095 on February 23, 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in